Researchers developed a deep learning framework for generating virtual immunostaining on label-free tissue to assess vascular invasion in thyroid cancer.
Key Details
- 1UCLA-led team created a cGAN-based virtual mIHC model for thyroid cancer assessment.
- 2Framework transforms label-free autofluorescence images into virtual stains for ERG, PanCK, and H&E.
- 3Traditional IHC requires one tissue section per stain and is prone to high cost and variability.
- 4The virtual method achieved high concordance with traditional staining, validated by pathologists.
- 5Virtual stains preserve tissue, reduce cost, and streamline diagnostic workflows.
- 6Blind evaluations confirmed accuracy in identifying vascular invasion.
Why It Matters
This innovation significantly improves efficiency, accuracy, and tissue preservation in pathological cancer assessment—a critical step closely intertwined with radiology and imaging AI. Streamlining virtual staining can broadly impact diagnostic workflows in cancer care and potentially extend to other diseases.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.